Specialty Areas: Pacemaker (including biventricular) and defibrillator implantation; Device extraction; Catheter ablation for SVT, VT, and atrial fibrillation; Outcomes research in atrial fibrillation with respect to symptom relief and catheter ablation; Interventional cardiology; Cardiovascular genetics; Vascular biology research and clinical cardiology research; Electrophysiology; General cardiology.
Chronology: M.Eng: Massachusetts Institute of Technology, 1996; MD: University of California, San Francisco, 2000; Intern and Resident: University of California, San Francisco, 2000-2003; Cardiology Fellowship: Mt. Sinai Medical Center, 2003-2006; Cardiac Electrophysiology Fellowship: Emory University, 2006-2008; Assistant Professor of Medicine: University of North Carolina, 2008-2014; Director, Fellowship in Clinical Cardiac Electrophysiology: University of North Carolina, 2012-present; Associate Professor of Medicine: University of North Carolina, 2014-present.
Dr. Gehi’s clinical interests include pacemaker and defibrillator implantation and device extraction, as well as catheter ablation for SVT, VT, atrial flutter, and atrial fibrillation. Dr. Gehi’s research focus includes techniques of ablation for atrial fibrillation (including hybrid ablation), processes of care in the management of atrial fibrillation, and outcomes research in atrial fibrillation through complex analyses of big data.
My career in academic electrophysiology is thoroughly rewarding. Clinically, it brings me great satisfaction to help a patient overcome the distress a dysrhythmia can produce. Whether by performing a catheter ablation, implanting a device, or simply providing reassurance that worrisome symptoms are benign, I truly enjoy helping patients through their illness. Additionally, my position also allows me to continue investigations into improving care for patients with cardiac dysrhythmia, by improving systems of care and developing more precise ablation techniques. Finally, I am able to help future physicians develop the knowledge and skills for success in medicine, cardiology, and electrophysiology.
Gehi AK, Deyo Z, Mendys P, Hatfield L, Laux J, Walker TJ, Chen S, O’Bryan J, Garner K, Sears SF Jr, Akiyama J, Stearns SC, Biese K. “Novel Care Pathway for Patients Presenting to the Emergency Department With Atrial Fibrillation.” Circ Cardiovasc Qual Outcomes. 2018 Jan;11(1):e004129.
King DR, Mehta ND, Gehi AK, Pursell I, Mounsey P, Kumar P, Bamimore A, Chung EH. “Minimally symptomatic atrial fibrillation patients derive significant symptom relief following rate control or rhythm control therapy.” J Clin Med Res. 2015 Sep; 7(9): 690-3.
Bode WD, Patel N, Gehi AK. “Left atrial appendage occlusion for prevention of stroke in nonvalvular atrial fibrillation: a meta-analysis.” J Interv Card Electrophysiol. 2015 Jun; 43(1): 79-89. Gehi AK, Kiser AC, Mounsey JP. “Atrial fibrillation ablation by the epicardial approach.” J Atr Fibrillation. Feb-Mar, 2014; 6(5): 70-76.
Gehi AK, Mounsey JP, Cherkur S, Kiser A. “Hybrid catheter and surgical ablation of atrial fibrillation: comparison of techniques.” American Heart Association, 2014.
Gehi AK, Goli N, Sears S, Chung EH, Wood K, Cohen J, Guise K, Walker TJ, Mounsey JP. “Somatization symptoms are associated with atrial fibrillation symptom severity.” Heart Rhythm Society, 2011.
Gehi AK, Mounsey JP. Atrial Fibrillation. Runge MS, Stouffer G, Patterson C, eds. Netter’s Cardiology. Saunders, 2010: 233-9.